Close
Nordic 9Nordic 9

Sound Bioventures (investor - Venture Capital)

Sweden soundbioventures.com
See something wrong or missing? Let us know
Offices:Malmö

Sound Bioventures is a venture capital fund from Sweden investing in about-to-be clinical or clinical stage private companies in Europe and USA developing therapies in specialty therapeutics areas

Average round investment:27.19M USD
Average number per year:2.7
Distribution: 2024 (3)2023 (4)2022 (1)
Portfolio companies: Sweden AnaCardioDenmark Breye TherapeuticsUnited Kingdom Theolytics See the entire list
Mostly invests in: Denmark Denmark (3) Health services (8)
See the entire list

Showing 3 of 8 tracked investments in:

You need an account to access this feature. Log in or create one from here.

Do you have a question? Talk to us.

Sound Bioventures mostly invests with:

You need an account to access this feature. Log in or create one from here.

Do you have a question? Talk to us.

Investors with similar profile to Sound Bioventures

Name Criteria
Sweden Creades
83%
  • Range for average deal size: 20M - 50M USD
  • Similar verticals: Health services, Pharma, Manufacturing
  • Similar business models: B2B
  • Common investees countries: Sweden
  • Average number of deals per year: 2.9
  • Active last 12 months: Yes
France Relyens Group
83%
  • Range for average deal size: 20M - 50M USD
  • Similar verticals: Health services, Biotech, Pharma, Manufacturing
  • Similar business models: B2B
  • Common investees countries: France
  • Average number of deals per year: 2.4
  • Active last 12 months: Yes
Belgium EBRD
83%
  • Range for average deal size: 20M - 50M USD
  • Similar verticals: Health services, Biotech, Pharma
  • Similar business models: B2B
  • Common investees countries: United Kingdom
  • Average number of deals per year: 2.4
  • Active last 12 months: Yes
Belgium Fundplus
83%
  • Range for average deal size: 20M - 50M USD
  • Similar verticals: Health services, Biotech, Pharma, Manufacturing
  • Similar business models: B2B
  • Common investees countries: France, Netherlands, Spain
  • Average number of deals per year: 3.0
  • Active last 12 months: Yes
Sweden HealthCap
83%
  • Range for average deal size: 20M - 50M USD
  • Similar verticals: Health services, Biotech, Pharma, Manufacturing
  • Similar business models: B2B
  • Common investees countries: Denmark, Sweden
  • Average number of deals per year: 2.3
  • Active last 12 months: Yes
Spain Ysios Capital
83%
  • Range for average deal size: 20M - 50M USD
  • Similar verticals: Health services, Biotech, Pharma, Manufacturing
  • Similar business models: B2B
  • Common investees countries: Denmark, France, Netherlands, Spain
  • Average number of deals per year: 3.0
  • Active last 12 months: Yes
United States OMX Ventures
83%
  • Range for average deal size: 20M - 50M USD
  • Similar verticals: Health services, Biotech, Manufacturing
  • Similar business models: B2B
  • Common investees countries: Denmark, United Kingdom
  • Average number of deals per year: 2.3
  • Active last 12 months: Yes
France IDIA Capital Investissement
83%
  • Range for average deal size: 20M - 50M USD
  • Similar verticals: Health services, Biotech, Manufacturing
  • Similar business models: B2B
  • Common investees countries: France
  • Average number of deals per year: 2.2
  • Active last 12 months: Yes
Luxembourg 3B Future Health Fund
83%
  • Range for average deal size: 20M - 50M USD
  • Similar verticals: Health services, Biotech, Pharma, Manufacturing
  • Similar business models: B2B
  • Common investees countries: United Kingdom, France
  • Average number of deals per year: 2.2
  • Active last 12 months: Yes
United Kingdom Ahren Innovation Capital
83%
  • Range for average deal size: 20M - 50M USD
  • Similar verticals: Health services, Biotech, Manufacturing
  • Similar business models: B2B
  • Common investees countries: United Kingdom
  • Average number of deals per year: 2.2
  • Active last 12 months: Yes
Top